<DOC>
	<DOCNO>NCT01991223</DOCNO>
	<brief_summary>To evaluate efficacy dexmedetomidine prevention catheter-related bladder discomfort</brief_summary>
	<brief_title>Dexmedetomidine Catheter-related Bladder Discomfort</brief_title>
	<detailed_description>After transurethral bladder resection , large-sized foley catheter use drainage urine residual blood . Because urinary catheterization , patient usually experience catheter-related bladder discomfort define burn sensation urge void discomfort supra-pubic region cause catheter- related bladder irritation . Dexmedetomidine alpha-2 antagonist use analgesic agent . The investigator try evaluate The efficacy dexmedetomidine treatment catheter-related bladder discomfort</detailed_description>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Patients schedule transurethral bladder resection ASA IIII Patient disagree participate investigation Patient severe cardiovascular disease Patient smallsized foley catheter ( le 18 Fr . ) Patinets urinary tract obstruction Patient hyperactive neurogenic bladder Patients chronic renal failure Patient morbidly obese Patients neurogenic disorder Patient medication chronic pain</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>